Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Return on Sales (2016 - 2025)

Palisade Bio (PALI) has disclosed Return on Sales for 15 consecutive years, with 585.4% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales changed N/A to 585.4% in Q3 2025 year-over-year; TTM through Sep 2025 was 1433.5%, a N/A change, with the full-year FY2023 number at 52.34%, changed N/A from a year prior.
  • Return on Sales was 585.4% for Q3 2025 at Palisade Bio, down from 1422.5% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2311.0% in Q1 2025 to a low of 57.64% in Q2 2023.
  • A 4-year average of 377.21% and a median of 4.35% in 2022 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: soared 90508bps in 2021, then tumbled -51215bps in 2023.
  • Palisade Bio's Return on Sales stood at 4.09% in 2021, then skyrocketed by 11075bps to 457.04% in 2022, then crashed by -111bps to 52.34% in 2023, then skyrocketed by 1218bps to 585.4% in 2025.
  • Per Business Quant, the three most recent readings for PALI's Return on Sales are 585.4% (Q3 2025), 1422.5% (Q2 2025), and 2311.0% (Q1 2025).